Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Reserpine (N1867): Practical Guidance for Research Applicati

    2026-04-13

    Reserpine (N1867): Technical Guidance for Research Use

    What This Product Solves

    Reserpine, chemically known as 3,20-Yohimban-16-carboxylic acid methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate, addresses core demands in experimental neuroscience and cardiovascular research. Its primary roles are as an established tool for neurotransmitter depletion research and in workflows examining antihypertensive mechanisms and neuropharmacological processes. The compound’s high purity (>98.8%, confirmed by HPLC and NMR) and stability under recommended conditions support reproducible, quantitative results in laboratory settings. For researchers seeking to modulate monoamine levels or model hypertension, Reserpine serves as a reference standard due to its well-characterized and consistent performance. However, it is not intended for diagnostic or therapeutic use.

    For detailed scenario-driven workflows and troubleshooting with Reserpine, see our internal guide: Optimizing Neurotransmitter Depletion. For protocol optimization in cell viability and neuropharmacology contexts, refer to: Scenario-Driven Solutions for Robust Assays.

    Protocol Parameters

    • Solubility assay | ≥13 mg/mL in DMSO (with gentle warming) | Solution preparation for in vitro and cell-based assays | Ensures adequate dissolution for precise dosing; water and ethanol are not suitable solvents | product_spec [source]
    • Storage stability | -20°C (solid, sealed, dry) | Long-term stock maintenance | Prevents degradation and maintains chemical integrity for repeated use | product_spec [source]
    • Working solution use | Prepare fresh; avoid long-term storage | Cell-based and biochemical assays | Reduces risk of compound instability and activity loss, ensuring consistent results | workflow_recommendation
    • Purity assessment | >98.8% (HPLC, NMR verified) | All quantitative and mechanistic studies | High purity supports reliable interpretation of experimental outcomes | product_spec [source]

    Workflow Setup and QC Checklist

    • Compound handling: Upon receipt, inspect the Reserpine vial for intact sealing and absence of moisture ingress. Store immediately at -20°C in a desiccated environment.
    • Solution preparation: Dissolve the compound in DMSO at concentrations up to 13 mg/mL, applying gentle warming if necessary. Avoid use of water or ethanol as solvents due to insolubility.
    • Aliquoting: For repeat experiments, prepare small aliquots to limit freeze-thaw cycles and reduce exposure to air and ambient humidity.
    • QC verification: Confirm transparency and absence of visible particulates in prepared solutions. If possible, verify concentration via UV-Vis or LC methods before use in critical assays.
    • Documentation: Record batch number, preparation date, and storage conditions for traceability and reproducibility.

    Common Failure Modes and Fixes

    • Incomplete dissolution: If undissolved material persists, increase temperature gently (avoid overheating) and agitate thoroughly. Do not use water or ethanol as this will not improve solubility.
    • Loss of activity in stored solutions: If experimental results are inconsistent, prepare a fresh working solution from the solid stock, as recommended by APExBIO and product guidelines.
    • Precipitation during use: If precipitation is observed in assay media, verify that DMSO concentrations are compatible with the biological system and that the final solution is well mixed prior to application.
    • Degradation due to improper storage: If a color change or odor develops, discard the stock and reconstitute from a new aliquot, ensuring proper -20°C, dry storage.

    Scope and Limitations

    Reserpine (SKU N1867) is designated for research use only, specifically in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. Its use is not validated for diagnostic or medical purposes. Protocols involving in vivo administration, clinical translation, or untested cell types should be independently optimized and are outside the scope of this guidance. As no direct paper evidence is available for this specific SKU, all numeric data and recommendations are derived from product specifications or workflow best practices. Compound stability, solubility, and purity claims are limited to the conditions and methods described by the supplier. Researchers are responsible for further validation in custom experimental contexts.

    Conclusion

    Reserpine (SKU N1867) offers a reliable, high-purity option for laboratory studies targeting neurotransmitter modulation and antihypertensive mechanism workflows. By adhering to the specified solubility and storage parameters, and by using freshly prepared solutions, researchers can maximize reproducibility and minimize experimental variability. For further details on experimental troubleshooting and advanced protocol scenarios, consult the product page at Reserpine and related internal workflow guides. APExBIO’s technical documentation and validated supply chain support rigorous application in research settings.